[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019

Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
Registered in



:: Volume 24, Issue 6 (2-2017) ::
Journal of Ilam University of Medical Sciences 2017, 24(6): 203-212 Back to browse issues page
Pharmaceutical Inhibitor Design against Cyclooxygenase2 to Reduce the Inflammation and Pain
Pouyan Asadi * 1, Elahe Alivaisi2 , Nazanin Norollahi moghadam3
1- Young Researchers and Elite Club, Gorgan Branch, Islamic Azad University, Gorgan, Iran , cellchem2016@gmail.com
2- Dept of Clinical Biochemistry, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran
3- Dept of Chemistry, Faculty of Science, University of Payam Noor Behshahr, Behshahr, Iran
Abstract:   (6352 Views)

Introduction: In the current study, to reduce the side effects of anti-inflammatory drugs and increase their specificity, a new pharmaceutical inhibitor was designed by computational Biology and Bioinformatics knowledge.

Materials & methods: For this purpose, first, 150000 compounds with medicinal properties from ZINC database and also the files related to the structure of the enzyme cyclooxygenase2 from RCSB (Research Collaboratory for Structural Bioinformatics) were extracted. After preparing them, all of these chemical compounds were docked with the target enzyme in order to select the best pharmaceutical inhibitor (ligand).

Findings: After checking the computation, 10 compounds of ligands that were the results of Docking, were selected according to the Gibbs free energy (least ΔG). Based on the results of the docking operation, inhibitor binding to cox2 causes conformational changes of enzyme, potential energy reduction, and increasing the stability of inhibitor-enzyme complex.

Discussion & conclusions: According to the results obtained from the study, the inhibitors can reduce the inflammation and pain in different inflammatory diseases, by placing in the active site on the basis of more specificity and finally less toxicity.

Keywords: Cyclooxygenase2, Molecular docking, Nonsteroidal anti-inflammatory drug, Virtual screening, molecular dynamics
Full-Text [PDF 638 kb]   (5381 Downloads)    
Type of Study: Research | Subject: biology
Received: 2016/01/25 | Accepted: 2016/05/2 | Published: 2017/03/12
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Asadi P, Alivaisi E, Norollahi moghadam N. Pharmaceutical Inhibitor Design against Cyclooxygenase2 to Reduce the Inflammation and Pain . J. Ilam Uni. Med. Sci. 2017; 24 (6) :203-212
URL: http://sjimu.medilam.ac.ir/article-1-3336-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 24, Issue 6 (2-2017) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 0.16 seconds with 41 queries by YEKTAWEB 4646